EDN3 and myeloid sarcoma: As for evidence coming from human studies, plasma levels of ET-1 and ET-3 are increased in MS patients with respect to control subjects, and increased CSF ET-1 concentrations have been associated with a poorer visual recovery in MS patients after an episode of optic neuritis [222,223].